Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.173,93
0,45%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Italia BIT Sanofi (SANF) Sanofi (SANF) Notizie

Sanofi

SANF
0,00
0,00 (0,00%)
- - Chiuso
Dati in Delay di 15 minuti
Borsa: Italia
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
02/5/202407:00GLOBEPress Release: Beyfortus real-world evidence published in..
30/4/202418:00GLOBEPress Release: Annual General Meeting of April 30, 2024
25/4/202407:30GLOBECommuniqué de presse : Sanofi réitère ses objectifs..
23/4/202407:00GLOBEPress Release: Rilzabrutinib LUNA 3 phase 3 study met..
17/4/202407:00GLOBECommuniqué de presse : De nouveaux résultats de phase II à..
12/4/202420:05GLOBESanofi: Information concerning the total number of voting..
08/4/202418:00GLOBESanofi - AGM 30.04.2024 - Availability of Preparatory..
22/3/202407:30GLOBEPress Release: Availability of the Q1 2024 Memorandum for..
15/3/202420:04GLOBESanofi: Informations relatives au nombre de droits de vote..
11/3/202407:00GLOBECommuniqué de presse : De nouveaux résultats de phase II..
24/2/202415:51GLOBEPress Release: Phase 2 results demonstrate rilzabrutinib..
23/2/202418:45GLOBEPress Release: Filing of the 2023 U.S. Form 20-F and French..
23/2/202407:00GLOBEPress Release: Dupixent® sBLA accepted for FDA Priority..
22/2/202419:02GLOBECommuniqué de presse : Le Conseil d’administration de Sanofi..
20/2/202423:40GLOBESanofi: Informations relatives au nombre de droits de vote..
16/2/202407:00GLOBECommuniqué de presse : Le Japon est le premier pays dans le..
15/2/202414:00GLOBECommuniqué de presse : Des données de phase II publiées dans..
05/2/202408:00GLOBEPress Release: Peer support, flexible work arrangements,..
01/2/202407:30GLOBEPress Release: Sanofi Delivers Solid Sales and Business EPS..
25/1/202420:30GLOBEPress Release: Dupixent® FDA approved as first and only..
23/1/202407:30GLOBECommuniqué de presse : Sanofi va acquérir Inhibrx, Inc. et..
17/1/202422:57GLOBESanofi: Informations relatives au nombre de droits de vote..
09/1/202407:30GLOBECommuniqué de presse : Brian Foard est nommé Responsable de..
21/12/202307:30GLOBEPress Release: Sanofi announces end of program evaluating..
18/12/202321:59GLOBESanofi: Information concerning the total number of voting..
15/12/202307:30GLOBEPress Release: Availability of the Q4 2023 Memorandum for..
15/12/202307:00GLOBECommuniqué de presse : L’EMA a rendu un avis favorable pour..
11/12/202322:08GLOBECommuniqué de presse : Déclaration au sujet de la..
11/12/202301:30GLOBECP : Sarclisa® (isatuximab) plus KRd améliore..
07/12/202307:35GLOBECP : L’essai de phase III consacré au Sarclisa® (isatuximab)..
07/12/202303:30GLOBEPress Release: Sanofi Pipeline Transformation to Accelerate..
27/11/202307:30GLOBECommuniqué de presse : Dupixent® a permis de réduire..
23/11/202318:00GLOBESanofi: Information concerning the total number of voting..
27/10/202307:31GLOBECommuniqué de presse : Un troisième trimestre solide, marqué..
27/10/202307:30GLOBECommuniqué de presse : Sanofi entame un nouveau chapitre de..
22/10/202321:00GLOBEPress Release: Dupixent® (dupilumab) Phase 3 Results show..
19/10/202312:00GLOBECommuniqué de presse : Sanofi livre les premiers médicaments..
18/10/202310:45GLOBEPress Release: TZIELD® Phase 3 data presented at ISPAD shows..
17/10/202320:18GLOBESanofi: Information concerning the total number of voting..
13/10/202316:00GLOBEPress Release: Late-breaking amlitelimab Phase 2b data..
04/10/202307:00GLOBEPress Release: Sanofi and Teva announce exclusive..
03/10/202307:30GLOBEPress Release: Sanofi announces agreement for potential..
26/9/202307:30GLOBECommuniqué de presse : La FDA accorde un examen prioritaire..
25/9/202309:00GLOBEPress Release: Once-weekly ALTUVIIIO® approved in Japan as a..
22/9/202307:30GLOBEPress Release: Availability of the Q3 2023 Memorandum for..
19/9/202308:30GLOBECommuniqué de presse : Sanofi soutient les communautés..
11/9/202320:02GLOBESanofi: Information concerning the total number of voting..
31/8/202307:30GLOBEPress Release: Sanofi announces changes to its Executive..
15/8/202321:24GLOBESanofi: Information concerning the total number of voting..
03/8/202321:21GLOBEPress Release: U.S. CDC Advisory Committee unanimously..
Apertura: Min: Max:
Chiusura:

La tua Cronologia

BIT
SANF
Sanofi
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network